Minerva Neurosciences (NERV) Return on Assets [ROA] (2014 - 2026)
Minerva Neurosciences' Return on Assets [ROA] came in at -35.20% for Q2 2026, up 13.26 percentage points from -48.46% a year earlier but down 7.65 percentage points from the prior quarter.
Powered by 
Analysis
Minerva Neurosciences (NERV) Return on Assets [ROA] (2014 - 2026) Analysis & Trends
For FY2025, Minerva Neurosciences' Return on Assets [ROA] was -20.95%, up 22.81 percentage points from FY2024.
- Return on Assets [ROA] carries a five-year change of -23.83 percentage points (FY2020 to FY2025).
- Going back by year, Return on Assets [ROA] was -43.76% in FY2024 (-5.04 pp), -38.72% in FY2023 (+9.85 pp), -48.57% in FY2022 (+25.50 pp) and -74.07% in FY2021 (-76.95 pp).
- The five-year range for quarterly Return on Assets [ROA] is -66.19% (Q3 2022) to -22.46% (Q4 2025).
- Year-over-year, Return on Assets [ROA] has increased for five consecutive quarters, with an average year-over-year change of +3.41 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Assets [ROA] over five years came in Q3 2023 (a gain of 36.03 percentage points), and the weakest in Q1 2022 (a drop of 69.88 percentage points).
- Business Quant data shows NERV's Return on Assets [ROA] at -27.55% (Q1 2026), -22.46% (Q4 2025) and -47.86% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Minerva Neurosciences | 158.21 Mn | 158.21 Mn | - | -35.20% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -35.20% |
| Mar 31, 2026 | -27.55% |
| Dec 31, 2025 | -22.46% |
| Sep 30, 2025 | -47.86% |
| Jun 30, 2025 | -48.46% |
| Mar 31, 2025 | -51.46% |
| Dec 31, 2024 | -51.47% |
| Sep 30, 2024 | -51.86% |
| Jun 30, 2024 | -51.21% |
| Mar 31, 2024 | -42.87% |
| Dec 31, 2023 | -36.13% |
| Sep 30, 2023 | -30.16% |
| Jun 30, 2023 | -31.90% |
| Mar 31, 2023 | -40.64% |
| Dec 31, 2022 | -42.97% |
| Sep 30, 2022 | -66.19% |
| Jun 30, 2022 | -64.56% |
| Mar 31, 2022 | -62.04% |
| Dec 31, 2021 | -51.92% |
| Sep 30, 2021 | -30.83% |
API Access
Minerva Neurosciences Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NERV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "NERV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NERV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();